231 related articles for article (PubMed ID: 12846127)
1. The multidisciplinary approach to bone metastases.
Blum RH; Novetsky D; Shasha D; Fleishman S
Oncology (Williston Park); 2003 Jun; 17(6):845-57; discussion 862-3, 867. PubMed ID: 12846127
[TBL] [Abstract][Full Text] [Related]
2. Metastatic bone disease and tumour-induced hypercalcaemia: treatment options.
Heatley S
Int J Palliat Nurs; 2004 Jan; 10(1):41-6. PubMed ID: 14966444
[TBL] [Abstract][Full Text] [Related]
3. Bone metastases from advanced cancers: clinical implications and treatment options.
Fitch M; Maxwell C; Ryan C; Löthman H; Drudge-Coates L; Costa L
Clin J Oncol Nurs; 2009 Dec; 13(6):701-10. PubMed ID: 19948468
[TBL] [Abstract][Full Text] [Related]
4. The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 2: Clinical studies and economic analyses.
Saba N; Khuri F
Oncology; 2005; 68(1):18-22. PubMed ID: 15775689
[TBL] [Abstract][Full Text] [Related]
5. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
[TBL] [Abstract][Full Text] [Related]
6. Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup.
Rordorf T; Hassan AA; Azim H; Alexandru E; Er O; Gokmen E; Güral Z; Mardiak J; Minchev V; Peintinger F; Szendroi M; Takac I; Tesarova P; Vorobiof D; Vrbanec D; Yildiz R; Yücel S; Zekri J; Oyan B; ;
Breast; 2014 Oct; 23(5):511-25. PubMed ID: 24986766
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials in metastatic breast cancer to bone: past--present--future.
Body JJ
Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
[TBL] [Abstract][Full Text] [Related]
8. [Bisphosphonates in malignant hypercalcemia and bone pain].
Lamy O
Rev Med Suisse Romande; 2004 Feb; 124(2):111-4. PubMed ID: 15095627
[TBL] [Abstract][Full Text] [Related]
9. Advances in the treatment of bone metastases.
Reich CD
Clin J Oncol Nurs; 2003; 7(6):641-6. PubMed ID: 14705479
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates: clinical experience.
Coleman RE
Oncologist; 2004; 9 Suppl 4():14-27. PubMed ID: 15459426
[TBL] [Abstract][Full Text] [Related]
11. Optimal management of metastatic bone disease.
Major P
Eur J Oncol Nurs; 2007; 11 Suppl 2():S32-7. PubMed ID: 17804294
[TBL] [Abstract][Full Text] [Related]
12. Bone metastases, general and clinical issues.
Greco C; Forte L; Erba P; Mariani G
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):337-52. PubMed ID: 21738111
[TBL] [Abstract][Full Text] [Related]
13. Skeletal disease contributes substantially to morbidity and mortality in patients with lung cancer.
Hirsh V
Clin Lung Cancer; 2009 Jul; 10(4):223-9. PubMed ID: 19632938
[TBL] [Abstract][Full Text] [Related]
14. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
Mystakidou K; Katsouda E; Stathopoulou E; Vlahos L
Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
[TBL] [Abstract][Full Text] [Related]
15. Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners.
Quinn RH; Randall RL; Benevenia J; Berven SH; Raskin KA
Instr Course Lect; 2014; 63():431-41. PubMed ID: 24720328
[TBL] [Abstract][Full Text] [Related]
16. Natural history and treatment of bone complications in prostate cancer.
Saad F; Clarke N; Colombel M
Eur Urol; 2006 Mar; 49(3):429-40. PubMed ID: 16431012
[TBL] [Abstract][Full Text] [Related]
17. Bone metastases: approaches to management.
Janjan N
Semin Oncol; 2001 Aug; 28(4 Suppl 11):28-34. PubMed ID: 11544573
[TBL] [Abstract][Full Text] [Related]
18. Treatment of metastatic bone disease in breast cancer: bisphosphonates.
Diel IJ; Solomayer EF; Bastert G
Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates in the prevention and treatment of bone metastases.
Ramaswamy B; Shapiro CL
Oncology (Williston Park); 2003 Sep; 17(9):1261-70; discussion 1270-2, 1277-8, 1280. PubMed ID: 14569853
[TBL] [Abstract][Full Text] [Related]
20. [Role of bone-density-conserving agents in the treatment for pain in patients with bone metastases].
Zhabina AS; Semiglazova TY
Vopr Onkol; 2015; 61(2):303-10. PubMed ID: 26087615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
